You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Rapid, reliable and repeatable platforms for cell-free prototyping

    SBC: SYNVITROBIO, INC.            Topic: SB152001

    Cell-free platforms are a disruptive technology that can dramatically speed up the design-build-test cycle of biomolecular engineering. However, most currently available cell-free platforms are optimized for protein expression rather than for prototyping. Synvitrobio proposes to develop and commercialize a next-generation cell-free platform that allows for rapid, low-cost, high-throughput, and rep ...

    SBIR Phase I 2016 Department of DefenseDefense Advanced Research Projects Agency
  2. Enabling extreme acceleration of graph analyticsin real-world applications

    SBC: Accelogic, LLC            Topic: SB152004

    Graph analytics have emerged as a prominent computational workload in the defense community, and are representative of fundamental kernels in national security applications. Processing speed is a fundamental requirement for these applications. Massively-parallel hardware architectures promise to increase the performance of graph analytics. However, significant improvements in software technologies ...

    SBIR Phase I 2016 Department of DefenseDefense Advanced Research Projects Agency
  3. Mycotoxin Neutralization Treatment

    SBC: Physical Optics Corporation            Topic: CBD152003

    To address the Chemical and Biological Defense programs (CBDs) need for medical countermeasures against mycotoxin intoxication, PhysicalOptics Corporation (POC) proposes to develop a new Mycotoxin Neutralization Treatment (MyNT). This proposed solution is based on neutralizingmycotoxin from its deleterious effects by acting on multiple levels of mycotoxin metabolism through the novel combination o ...

    SBIR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense
  4. Mycotoxin Adsorption with Hemocompatible Porous Polymer Beads

    SBC: CYTOSORBENTS MEDICAL INC            Topic: CBD152003

    Acute exposure to mycotoxins can lead to systemic toxicity and even death. With no specific treatment available, aflatoxin and trichothecene T-2toxin, in particular, are of concern as potential biological weapons due to their toxicity, thermal and UV stability and easy accessibility. As amedical countermeasure, we propose the development of highly porous polymer beads optimized for removal of afla ...

    SBIR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense
  5. Exploiting Natural Products-Based Therapeutics for Aflatoxin Mitigation

    SBC: CFD RESEARCH CORPORATION            Topic: CBD152003

    Aflatoxins are a paradigm among fungal produced mycotoxins that are present in food supplies and are strongly associated with increased risk forthe development of hepatocellular carcinoma. Currently, there are no known countermeasures that can selectively mitigate aflatoxin toxicity andthe available options are only symptomatic treatments. To meet this challenge, we propose to harness the microbio ...

    SBIR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense
  6. Plasmid-seeded aligned nanofibrillar scaffold for acute muscle injury treatment

    SBC: Fibralign Corporation            Topic: DHP14009

    Based on encouraging Phase I feasibility results, we propose developing a novel gene therapy approach to promote guided vascular regeneration in treating extremities after traumatic injury. Our approach is to provide thread-like implants comprised of aligned nanofibrillar collagen scaffolds loaded with Hepatocyte Growth Factor (HGF) vectors (e.g., HGF DNA plasmid, modified mRNA) designed to enhanc ...

    SBIR Phase II 2016 Department of DefenseDefense Health Agency
  7. Table- top 3-D real time holographic nanoscope

    SBC: XUV LASERS, INC.            Topic: ST15C001

    We propose to develop a high-resolution soft x-ray nanoscope based on Fourier Transform Holography which has the very important advantage for real time visualization: 3D images are nearly instantaneously retrieved with a simple 2D Fast Fourier Transform operation. The table-top soft x-ray nanoscope will use for illumination a compact high average power soft x-ray laser that generates high e ...

    SBIR Phase I 2016 Department of DefenseDefense Advanced Research Projects Agency
  8. Analog Co-Processors for Complex System Simulation and Design

    SBC: Ocius Technologies LLC            Topic: ST15C002

    The objective is to design an analog (time-continuous) radiofrequency (RF) computation platform in the form of a software-defined RF integrated-circuit (IC) with supplementary digital logic for solving differential equation based simulations at speeds that are 1-2 orders of magnitude greater than available digital high-performance computation platforms. The maximum speed that the state-of-the-art ...

    SBIR Phase I 2016 Department of DefenseDefense Advanced Research Projects Agency
  9. Analog Co-Processors for Complex System Simulation and Design

    SBC: Arete Associates            Topic: ST15C002

    It has long been known that analog computers can be faster and more power efficient than digital processors by many orders of magnitude. Until the 1970s analog computers were the dominant controllers in most industrial and military applications. Even today digital processors are still slower and more power consumptive than analog, but offer much more flexibility (programmability) and precision. ...

    SBIR Phase I 2016 Department of DefenseDefense Advanced Research Projects Agency
  10. Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion

    SBC: CYTOSORBENTS MEDICAL INC            Topic: DHP15B001

    The ready availability of universal donor plasma to rapidly treat massively bleeding hospital trauma patients and warfighters with combat casualties is a key element of current recommendations for trauma resuscitation, yet universal AB donor plasma is rel

    SBIR Phase I 2016 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government